Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KYNTRA BIO, INC.FGEN · Entity 7431 | Director | September 15, 2021 | September 17, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KYNTRA BIO, INC.
Report date September 15, 2021 · Filed September 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 39,764 |
Reported balance
After 2021-09-15 transaction · row 1
1 source rowRow 1 · 2021-09-15 · Sale · Disposed 13,100 · Balance 39,764 F1: These shares were sold in multiple transactions on the reported date with prices ranging from $11.46 to $11.615 resulting in a weighted average price of $11.5807. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 110,000 |
Reported balance
Holding disclosure · report date 2021-09-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 110,000 |
| Common StockSEC Table I · non-derivative | IndirectBy LLC | 100,000 |
Reported balance
Holding disclosure · report date 2021-09-15 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 100,000 F2: Shares are held by Go Heels, LLC. The reporting person is Manager and Sole Member of Go Heels and has voting and investment control with respect to the shares held by Go Heels, LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold in multiple transactions on the reported date with prices ranging from $11.46 to $11.615 resulting in a weighted average price of $11.5807. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction.
F2: Shares are held by Go Heels, LLC. The reporting person is Manager and Sole Member of Go Heels and has voting and investment control with respect to the shares held by Go Heels, LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2021 Filed Sep 17, 2021 20:02 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 13,100 | $11.58 | $151,707.17 |
DisclosureSEC source: 0001209191-21-056604 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,764 F1 · price: These shares were sold in multiple transactions on the reported date with prices ranging from $11.46 to $11.615 resulting in a weighted average price of $11.5807. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:06 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036679 · doc4.xml · derivative · entry 4 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F3 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:06 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036679 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,864 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:22 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-21-020548 · doc4.xml · derivative · entry 5 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2021-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:22 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-21-020548 · doc4.xml · derivative · entry 4 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2021-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:22 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 18,000 | $35.02 | $630,360.00 |
DisclosureSEC source: 0001209191-21-020548 · doc4.xml · nonDerivative · entry 2 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,164 F1 · price: The shares were sold at prices ranging from $34.71 to $35.395. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:22 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 18,000 | $3.50 | $63,000.00 |
DisclosureSEC source: 0001209191-21-020548 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:28 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035152 · doc4.xml · derivative · entry 3 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:28 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035152 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,164 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:37 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-20-020706 · doc4.xml · derivative · entry 5 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2020-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:37 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-20-020706 · doc4.xml · derivative · entry 4 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2020-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:37 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 18,000 | $23.17 | $417,074.40 |
DisclosureSEC source: 0001209191-20-020706 · doc4.xml · nonDerivative · entry 2 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,464 F1 · price: The shares were sold at prices ranging from $22.67 to $23.55. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:37 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 18,000 | $2.90 | $52,200.00 |
DisclosureSEC source: 0001209191-20-020706 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 23:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $39.03 | $0.00 |
DisclosureSEC source: 0001209191-19-035653 · doc4.xml · derivative · entry 3 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2029-06-05 F2 · derivative.exercise_date: Options vest on the earlier of June 5, 2020 or the date of the next annual meeting of stockholders. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 23:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035653 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,464 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 5, 2020 or the date of the next annual meeting of stockholders. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 23:29 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $55.30 | $0.00 |
DisclosureSEC source: 0001209191-18-036512 · doc4.xml · derivative · entry 3 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2028-06-05 F2 · derivative.exercise_date: Options vest on the earlier of June 6, 2019 or the date of the next annual meeting of stockholders. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 23:29 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 3,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-036512 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,764 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 6, 2019 or the date of the next annual meeting of stockholders. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 00:20 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001209191-18-019435 · doc4.xml · derivative · entry 6 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2019-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 00:20 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $3.60 | $0.00 |
DisclosureSEC source: 0001209191-18-019435 · doc4.xml · derivative · entry 5 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2019-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 00:20 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 18,000 | $55.00 | $990,000.00 |
DisclosureSEC source: 0001209191-18-019435 · doc4.xml · nonDerivative · entry 3 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,064 F1 · price: The shares were sold at prices ranging from $54.70 to $55.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 00:20 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 18,000 | $3.60 | $64,800.00 |
DisclosureSEC source: 0001209191-18-019435 · doc4.xml · nonDerivative · entry 2 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2018 Filed Mar 14, 2018 00:20 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019435 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,064 Read SEC document |
| December 05, 2017 Filed Feb 15, 2018 01:04 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010198 · doc5.xml · nonDerivative · entry 4 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,564 Read SEC document |
| November 27, 2017 Filed Feb 15, 2018 01:04 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010198 · doc5.xml · nonDerivative · entry 3 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,064 Read SEC document |
| November 20, 2017 Filed Feb 15, 2018 01:04 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010198 · doc5.xml · nonDerivative · entry 2 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,064 Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001209191-17-061637 · doc4.xml · derivative · entry 5 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2018-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001209191-17-061637 · doc4.xml · derivative · entry 4 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2018-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 18,000 | $45.22 | $813,960.00 |
DisclosureSEC source: 0001209191-17-061637 · doc4.xml · nonDerivative · entry 2 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,564 F1 · price: The shares were sold at prices ranging from $44.85 to $45.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 18,000 | $2.35 | $42,300.00 |
DisclosureSEC source: 0001209191-17-061637 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2017 Filed Feb 15, 2018 01:04 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010198 · doc5.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,564 Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 23:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (right to Buy) · Derivative | 12,000 | $0.00 Strike: $28.65 | $0.00 |
DisclosureSEC source: 0001209191-17-038677 · doc4.xml · derivative · entry 6 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-07 F3 · derivative.exercise_date: The shares subject to the option vest and become exercisable quarterly over one year measured from June 7, 2017. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 23:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $9.78 | $0.00 |
DisclosureSEC source: 0001209191-17-038677 · doc4.xml · derivative · entry 5 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2023-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 23:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $9.78 | $0.00 |
DisclosureSEC source: 0001209191-17-038677 · doc4.xml · derivative · entry 4 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2023-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 23:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 18,000 | $28.71 | $516,780.00 |
DisclosureSEC source: 0001209191-17-038677 · doc4.xml · nonDerivative · entry 2 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,564 F1 · price: The shares were sold at prices ranging from $28.275 to $29.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 23:51 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 18,000 | $9.78 | $175,950.00 |
DisclosureSEC source: 0001209191-17-038677 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2016 Filed Feb 11, 2017 00:32 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009783 · doc5.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,564 Read SEC document |
| November 18, 2016 Filed Nov 19, 2016 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001209191-16-151318 · doc4.xml · derivative · entry 8 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2017-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| November 18, 2016 Filed Nov 19, 2016 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001209191-16-151318 · doc4.xml · derivative · entry 7 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2017-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| November 18, 2016 Filed Nov 19, 2016 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 13,000 | $22.47 | $292,132.10 |
DisclosureSEC source: 0001209191-16-151318 · doc4.xml · nonDerivative · entry 4 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,564 F2 · price: The shares were sold at prices ranging from $22.35 to $22.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 18, 2016 Filed Nov 19, 2016 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 13,000 | $4.03 | $52,325.00 |
DisclosureSEC source: 0001209191-16-151318 · doc4.xml · nonDerivative · entry 3 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2016 Filed Nov 19, 2016 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001209191-16-151318 · doc4.xml · derivative · entry 6 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 5,000 shares Expires 2017-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| November 17, 2016 Filed Nov 19, 2016 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,000 | $22.21 | $111,028.00 |
DisclosureSEC source: 0001209191-16-151318 · doc4.xml · nonDerivative · entry 2 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,564 F1 · price: The shares were sold at prices ranging from $22.10 to $22.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 17, 2016 Filed Nov 19, 2016 00:11 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,000 | $4.03 | $20,125.00 |
DisclosureSEC source: 0001209191-16-151318 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.